CROs offering Translational Research with Vaccine
23 published
23 published CROs match Translational Research and Vaccine.
Locations in this set include United States, China, India, Australia, Belgium, and Netherlands.
Capabilities that show up most often in this set: Regulatory Affairs, Biomarker Assays, Bioanalysis, GLP Toxicology, and Preclinical In Vivo Studies.
Matching companies
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
TigermedLeading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /explore/translational-research/vaccine.md